Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Track this trialSee every version on ClinicalTrials.gov ↗
| NCT Number | NCT07146412 |
| Lead Sponsor | HudsonAlpha Institute for Biotechnology |
| Conditions (from sponsor) |
Cognitive Impairment, Alzheimer Blood Biomarkers, Alzheimer Disease (AD), Mild Cognitive Impairment (MCI) |
| Related terms | Alzheimer Disease, Cognitive Dysfunction |
| Enrollment | 200 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |